COMMUNIQUÉ DE PRESSE publié le 19/10/2023 à 14:30, il y a 2 années 1 mois Independent Study Conducted at Boston Children's Hospital, Harvard Medical School, Shows Potential Utility of Jaguar Health's Crofelemer for Treatment of MVID, a Rare Childhood Disease
COMMUNIQUÉ DE PRESSE publié le 18/10/2023 à 14:30, il y a 2 années 1 mois Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
COMMUNIQUÉ DE PRESSE publié le 12/10/2023 à 14:30, il y a 2 années 1 mois Jaguar Health to Present October 17 at the Lytham Partners Fall 2023 Investor Conference and October 18 at the BIO Investor Forum
COMMUNIQUÉ DE PRESSE publié le 10/10/2023 à 14:30, il y a 2 années 1 mois Jaguar Animal Health Exhibiting at October 12-14 VCS Annual Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 14:30, il y a 2 années 2 mois Jaguar Health to Present October 3 at LD Micro's Main Event Investor Conference, and on October 5 at the Global Capital Network Investor Conference
COMMUNIQUÉ DE PRESSE publié le 27/09/2023 à 14:30, il y a 2 années 2 mois Jaguar Health Launches TikTok and Instagram Contest to Raise Awareness About Common Yet Barely Addressed Health Condition: Surprise Diarrhea
COMMUNIQUÉ DE PRESSE publié le 26/09/2023 à 14:30, il y a 2 années 2 mois Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
COMMUNIQUÉ DE PRESSE publié le 21/09/2023 à 13:30, il y a 2 années 2 mois Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating ADHD
COMMUNIQUÉ DE PRESSE publié le 14/09/2023 à 14:30, il y a 2 années 2 mois Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference
COMMUNIQUÉ DE PRESSE publié le 13/09/2023 à 14:30, il y a 2 années 2 mois Patent Issued in Japan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Publié le 05/12/2025 à 17:18, il y a 4 heures 35 minutes La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Publié le 05/12/2025 à 17:18, il y a 4 heures 35 minutes The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Publié le 05/12/2025 à 15:10, il y a 6 heures 42 minutes Mersen: Number of shares and voting rights as of November 30, 2025
Publié le 05/12/2025 à 15:10, il y a 6 heures 42 minutes Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Publié le 05/12/2025 à 13:58, il y a 7 heures 55 minutes RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Publié le 05/12/2025 à 21:45, il y a 8 minutes When the Architecture Becomes Visible: The SMX Revaluation Explained
Publié le 05/12/2025 à 21:30, il y a 23 minutes The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Publié le 05/12/2025 à 21:20, il y a 33 minutes Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Publié le 05/12/2025 à 21:00, il y a 53 minutes The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Publié le 05/12/2025 à 20:25, il y a 1 heure 28 minutes The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Publié le 05/12/2025 à 18:58, il y a 2 heures 55 minutes EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Publié le 05/12/2025 à 18:15, il y a 3 heures 38 minutes Completion of merger to form Helvetia Baloise Holding Ltd
Publié le 05/12/2025 à 17:46, il y a 4 heures 7 minutes Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
